Pancreatic Cancer and BRCA: What You Need to Know
A common misconception is that BRCA1 and BRCA2 genes are associated with hereditary breast and ovarian cancers alone. In fact, mutations in BRCA1 and BRCA2 also significantly increase the risk of pancreatic cancer — a connection that is critically underappreciated.
The BRCA–Pancreatic Cancer Connection
Individuals with BRCA2 mutations have a 3–6 times higher risk of developing pancreatic cancer compared to the general population. BRCA1 mutations also confer an elevated risk, though somewhat lower than BRCA2. Other genes associated with elevated pancreatic cancer risk include PALB2, ATM, MLH1, MSH2 (Lynch Syndrome), and CDKN2A.
Challenges in Diagnosis
Pancreatic cancer is notoriously difficult to detect early — it rarely causes symptoms until it has spread beyond the pancreas. For individuals with known BRCA mutations or a strong family history of pancreatic cancer, enhanced surveillance protocols (including endoscopic ultrasound and MRI) can detect the disease at an earlier, more treatable stage.
Non-Genetic Risk Factors
Smoking — smokers are 2–3 times more likely to develop pancreatic cancer
Long-standing Type 2 diabetes
Obesity and a high-fat, high-calorie diet
Chronic pancreatitis
Go Beyond BRCA — Know Your Full Hereditary Cancer Risk
Oncomap by MapmyGenome screens for hereditary risk across BRCA1/2 and dozens of other cancer predisposition genes — including pancreatic cancer risk genes. Includes certified genetic counselling and a CAP & NABL-accredited laboratory.
